tions. Only three cases of Hb H disease have been reported in Pacific Islanders, all from Papua New Guinea.F6 The molecular basis of Hb H disease has been extensively investigated in Euroasian populations (reviewed in reference 2). In most cases it results from the presence of a single a gene deletion (-a/) on one chromosome 16 and also a larger deletion which removes both the duplicated a globin genes (--/) on the other chromosome 16. The larger deletion which is the a' thalassaemia determinant is remarkably population specific. In South-east Asians a 20 kilobase (kb) deletion is commonly found7 and in Mediterraneans either a 17-5 kb, a 20-5 kb, or a 5-2 kb deletion is found. Less commonly, much larger deletions removing the whole a globin gene complex or non-deletion defects, point mutations, have been shown to cause Hb H disease.
As part of a larger study of the distribution and molecular basis of a thalassaemia in Melanesian mutation of the a2 globin gene (ATG--ACG) which abolishes a site for the restriction enzyme NcoI. DNA from the proband in this Papuan family was digested with NcoI and hybridised with the a globin probe. Only the normal 4-8, 3-7, and 2-1 kb bands were observed, indicating the absence of the Sardinian mutation. The relatively common type of non-deletion Hb H disease first reported in Saudi Arabians,17 and now known to be more widely distributed in the Middle East and parts of the Mediterranean,'4 is due to homozygosity for a point mutation in the polyadenylation signal sequence of the a2 gene (AATAAA-AATAAG); the sequence of the al gene is normal on these chromosomes.14 Because there is no restriction enzyme which recognises this sequence change, two oligonucleotides were used, one (a2 normal) is completely homologous to the 3' end of the normal a2 gene sequence, the other (a2 mutant) to the corresponding sequence on the chromosome with the polyadenylation signal mutation. After digestion with PvuII the a2 normal oligonucleotide but not the a2 mutant oligonucleotide hybridised to the 2-0 kb a2 specific fragment.
Hence, a polyadenylation signal mutation is not responsible for this Papuan form of Hb H disease.
Discussion
This study of a Melanesian family has revealed that, unusually, none of the a globin genes is deleted in subjects with Hb H disease. Further analysis showed that the molecular defect responsible for Hb H disease in this Papuan family is different from those found in the Middle East and Sardinia. A common problem in this sort of molecular analysis is to distinguish between the presence of two intact but dysfunctional gene complexes (denoted aa/aa or sometimes aaT/aaT) and heterozygosity for a total deletion of one gene complex (--/aa or --/aaT). Judgements based solely on band intensities are often unreliable. Here, although analysis of numerous restriction enzyme site polymorphisms failed to distinguish between these interpretations, it was possible to show the presence of both complexes by analysis of the very informative length polymorphism 3' to the a genes.
The heterozygosity at this 3'HVR of these Papuans with Hb H disease raises the question of whether the non-deletion defect on each of their chromosomes is the same. This has been shown to be so in both the Saudi Arabian and Sardinian cases of non-deletion Hb H disease. However, such persons from Saudi Arabia have been shown to be homozygous for a particular 3'HVR as well as a particular restriction enzyme haplotype (haplotype la). 14 This is as might be expected assuming a single, relatively recent origin for a particular point mutation. In this Papuan form of Hb H disease it is possible that the mutations on the two chromosomes are identical and that a length mutation of the 3'HVR occurred after the mutation affecting a globin production. Alternatively, the red cell indices of the children who have inherited one or other non-deletion allele in this family (tables 1 and 2) might be seen to support the possibility that the proband is a compound heterozygote, in that it appears that the chromosome with the 2.1 kb 3'HVR allele may be associated with a more severe form of a thalassaemia than the chromosome with the 2-3 kb allele. Clearly, the latter chromosome does not carry an a' thalassaemia determinant because when found in association with a a4 2 deletion (subject 11. 
